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Abstract
Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and
subtropical regions. There is currently no effective drug or vaccine formulation for the prevention of DF and its more severe
forms, i.e., dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). There are two generally available
experimental models for the study of DENV pathogenicity as well as the evaluation of potential vaccine candidates. The first
model consists of non-human primates, which do not develop symptoms but rather a transient viremia. Second, mouse-
adapted virus strains or immunocompromised mouse lineages are utilized, which display some of the pathological features
of the infection observed in humans but may not be relevant to the results with regard to the wild-type original virus strains
or mouse lineages. In this study, we describe a genetic and pathological study of a DENV2 clinical isolate, named JHA1,
which is naturally capable of infecting and killing Balb/c mice and reproduces some of the symptoms observed in DENV-
infected subjects. Sequence analyses demonstrated that the JHA1 isolate belongs to the American genotype group and
carries genetic markers previously associated with neurovirulence in mouse-adapted virus strains. The JHA1 strain was lethal
to immunocompetent mice following intracranial (i.c.) inoculation with a LD50 of approximately 50 PFU. Mice infected with
the JHA1 strain lost weight and exhibited general tissue damage and hematological disturbances, with similarity to those
symptoms observed in infected humans. In addition, it was demonstrated that the JHA1 strain shares immunological
determinants with the DENV2 NGC reference strain, as evaluated by cross-reactivity of anti-envelope glycoprotein (domain
III) antibodies. The present results indicate that the JHA1 isolate may be a useful tool in the study of DENV pathogenicity
and will help in the evaluation of anti-DENV vaccine formulations as well as potential therapeutic approaches.
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Introduction
Infection with one of the four dengue virus (DENV) serotypes
can be asymptomatic or can trigger a wide spectrum of clinical
manifestations. The disease may yield symptoms ranging from
a mild acute febrile illness, termed dengue fever (DF), to the more
severe forms of the disease that include dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS), characterized by fever,
hemorrhage, thrombocytopenia, vascular leakage and viremia that
is 10- to 100-fold greater than in DF [1]. The cellular and
molecular mechanisms involved in DENV pathogenesis remain, at
least in part, elusive. The current hypotheses regarding the
mechanisms involved in dengue pathogenicity and the severity of
disease symptoms range from dysfunction of the host immune
system, with the generation of cross-reactive antibodies and T
cells, to platelet depletion, endothelial cell apoptosis and comple-
ment activation with damage to host tissues [2–7].
The general health state and genetic profile of the host as well as
the virulence variability among the DENV strains contribute to
the severity of the disease symptoms and development of DHF/
DSS [8–11]. However, the lack of a more suitable animal model
for the study of the disease is a clear drawback to determining
DENV pathogenesis and the immunological mechanisms involved
in the disease progression or protection [12]. As a corollary, no
effective anti-DENV drug or vaccine formulation is presently
available for the treatment or prevention of the disease [13].
Humans and mosquitoes represent the only natural hosts for
dengue viruses known to date. Some non-human primates are
permissive to DENV and elicit specific immune responses, but
they develop only transient viremia, without the specific symptoms
observed in infected humans [14–17]. In addition, for ethical and
economic reasons, non-human primates do not represent a sustain-
able option for the routine research of DENV pathogenicity.
Different mouse-based models have been intensively explored as
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experimental alternatives for the study of DENV pathogenesis and
efficacy evaluation of anti-DENV vaccines [12].
Although representing a simple and straightforward tool for the
study of DENV pathogenesis, mouse-based DENV infection
models have several limitations. First and perhaps most impor-
tantly, wild-type DENV strains usually do not infect and kill mice.
Thus, the DENV strains used in these studies must be adapted to
this new host by serial passages in the brains of suckling mice
[18,19]. During this selective process, different mutations in genes
encoding structural and non-structural proteins are selected and
confer the ability to replicate and kill the new host of the virus [19–
23]. However, some of these mutations are expected to change
different aspects of the virus physiology, such as cell and tissue
tropism as well as the replication rate. Therefore, experimental
models based on genetically modified virus strains are expected to
have reduced relevance regarding the understanding of viral
pathogenicity under natural conditions. Other DENV infection
model approaches rely on immunocompromised mouse lineages
that lack, for example, genes encoding IFN-c and IFN-a/
b receptors and thus allow the replication of non-adapted DENV
strains [24,25]. Therefore, due to the complex regulatory roles
played by these cytokines, the results based on immunodeficient
lineages do not necessarily reproduce the conditions expected to
be found in immunocompetent mouse lineages or humans [24,25].
Previous reports indicated that the ability of the mouse-adapted
DENV strains to kill immunocompetent mice following adminis-
tration via the intracranial (i.c.) route is a consequence of the
selection of specific mutations during the adaptation process that
allow them to replicate and cause encephalitis and death in these
animals [18,20]. In contrast, a previous report of a non-adapted
DENV strain capable of infecting and killing immunocompetent
mice [26] indicates that the DENV natural genetic plasticity may
represent the source of a more suitable DENV infection model for
murine hosts. However, the characterization of such a DENV
strain as an experimental model for the study of viral pathogenicity
and/or the testing of prophylactic and therapeutic interventions
has not been fully conducted.
In this study, we characterized a DENV strain recovered from
a symptomatic subject that is naturally lethal to immunocompetent
mice following i.c. administration. Genetic analysis of the isolate
revealed that it is a DENV2 strain grouped within the American
genotype. Amino acid sequence analyses demonstrated that the
virus strain, named JHA1, has specific polymorphic markers of
neurovirulence in mice. The infection with the DENV2 strain
induced body weight loss, general tissue damage, altered
hematological features indicative of plasma leakage, leucopenia,
lymphocytopenia, neutropenia and hemorrhage in Balb/c mice.
In addition, the JHA1 strain shares immunological determinants
with the NGC strain, a reference DENV2 widely used in the
testing of potential anti-dengue vaccine candidates. Collectively,
these results indicate that the new DENV2 isolate exhibits several
attributes of useful experimental models for studies aimed at
understanding viral pathogenicity and vaccine testing.
Materials and Methods
Ethics Statement
All handling procedures and experiments involving mice were
approved by the Committee for the Ethical Use of Laboratory
Animals from the Institute of Biomedical Sciences of the
University of Sa˜o Paulo, in accordance with the recommendations
in the guidelines for the care and use of laboratory animals of the
National Committee on the Ethics of Research (CONEP). Serum
sampling of human beings were approved by the Committee for
Ethics in Research Involving Human Beings of the Tropical
Medicine Institute of the University of Sa˜o Paulo and all subjects
provided written informed consent.
Serum Sampling and Viral Isolation
The human serum sample used in the present study was
obtained from the Laboratory of Virology-LIM5 collection, at the
Tropical Medicine Institute, University of Sa˜o Paulo. The serum
sample was originally collected at the city of Bele´m (Para´ Federal
State), in the northern region of Brazil, during the acute phase (day
4 after the symptoms onset) of the disease in a hospitalized patient
with dengue fever. The virus was isolated after cultivation in the
C6/36 cell lineage [27], as previously described [28,29].
Lethality and Propagation of Dengue Virus in Balb/c Mice
Once isolated, the DENV sample was propagated once in C6/
36 cells. The cells were cultured in Leibovitz-15 medium (L-15)
(Invitrogen, USA) supplemented with 5% fetal bovine serum (FBS)
(Gibco, USA). The culture supernatant was collected, divided into
aliquots and stored at 280uC or immediately titrated using
a plaque assay on LLC-MK2 cells, as previously described [26].
Male Balb/c mice (9 weeks old; n = 20) were anesthetized with
a mixture of ketamine and xylazine [30] and injected intracrani-
ally (i.c.) with 40 mL of L-15 medium supplemented with 5% FBS
containing 4,000 plaque-forming units (PFU) or media only (mock
group). Mice injected with virus (n = 10) were euthanized in the
moribund state, 5 days post-infection (p.i.), and the brains were
removed and individually macerated in 3 mL of DMEM medium
(Gibco, USA) at 4uC. The brain macerates were combined in a 50-
mL plastic tube and centrifuged at 405 g for 5 min. The
supernatant was harvested, divided into aliquots and stored at
280uC for the virus seed stock. Five randomly chosen aliquots
were subsequently titrated by plaque assay on LLC-MK2 cells.
Nucleotide Sequence and Phylogenetic Analysis
For DENV RNA extraction, 250 mL of an aliquot of the C6/36
cell culture supernatant, collected 4 days after infection with the
DENV isolate, was admixed with 750 mL of TRIzol reagent
(Invitrogen, USA) and incubated at room temperature for 5 min.
A volume of 200 mL of chloroform was added to the initial
mixture and incubated for 15 min at room temperature. The
mixture was centrifuged at 20,000 g for 10 min at 8uC, and the
aqueous phase was collected, added to 500 mL of isopropanol and
incubated for 10 min at room temperature. The tube was again
centrifuged at 20,000 g for 10 min at 8uC, the supernatant was
removed, and the pellet was washed with 75% ethanol (v/v). The
pellet was air dried and finally suspended in 20 mL of DEPC-
treated water [31]. The extracted RNA was stored at 280uC or
immediately subjected to reverse transcription-polymerase chain
reaction (RT-PCR) using a specific primer set, according to the
manufacturer’s instructions (SuperScript III First-Strand Synthesis
SuperMix, Invitrogen, USA). For the amplification reaction, the
sense primer used was 59-GGAATGTCATACTCTAT-39, and
the anti-sense primer was 59-TTACGATA-
GAACTTCCTTTCTTA-39. The amplified sequence encom-
passed nucleotides 1822 to 3477 of the virus genome, which
includes the beginning of domain III of the envelope glycoprotein
(EIII) coding sequence to the end of the NS1 coding sequence.
The amplified band was purified with the IlustraTM GFXTM PCR
DNA and Gel Band Purification Kit (GE Healthcare Life
Sciences, USA) and was directly used in the sequencing reactions.
The sample was sequenced four times in both orientations
(MegaBACE Sequencer, GE Healthcare, USA). The nucleotide
sequence obtained was submitted to GenBank (accession number
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JQ686088) and aligned with other DENV- and yellow fever virus-
equivalent nucleotide sequences using the ClustalW tool. The
alignments were used to construct a midpoint-rooted phylogenetic
tree by the neighbor-joining method using the Tamura Nei model,
implemented by the software MEGA 5.05, with 1,000 bootstrap
replicates [32,33]. Amino acid polymorphism analyses were
performed via alignment of the inferred amino acid sequence
with sequences from strains of the same genotype, i.e., the India/
1957 and Indonesia/1977 strains (GenBank accession numbers
FJ538927 and GQ398257, respectively), and the New Guinea C
(NGC) strain, which is a reference virus strain selected for
neurovirulence in mice (GenBank accession number M29095).
The markers for mouse neurovirulence were searched according
to a previous report [20]. The comparisons were performed with
the amino acid sequences corresponding to part of the envelope
glycoprotein (domain III, the adjacent stem-anchor region and the
NS1 signal peptide) of the JHA1, India/1957 and Indonesia/1977
strains and with the entire envelope glycoprotein sequence of the
NGC strain. Similar analyses were performed with the complete
amino acid sequence of the mature NS1 protein of the four
DENV2 strains.
Determination of the LD50 in Mice and Pathological
Symptoms Induced by the JHA1 Isolate
Male Balb/c mice (9 weeks old) were divided into seven groups
(n = 10), which were administered i.c. viral loads containing 25, 50,
100, 150, 200 or 300 PFU diluted to a final volume of 40 mL with
DMEM. A mock group was injected with DMEM alone. The
animals were monitored daily for mortality and changes in body
weight, which were recorded over a period of 21 days. The body
weight loss was daily calculated for each animal until the day of
death or the conclusion of the monitoring period and represented
as the percentage of the final weight compared to the initial
weight. Seven days post injection (p.i.), the animals were bled via
the retro-orbital plexus for the individual determination of
hematocrit and lactate dehydrogenase (LDH) levels. For hemat-
ocrit determination, heparinized microcapillary tubes (Precision
Glass Line, CRAL, Brazil) were filled with blood samples,
centrifuged at 4,000 g for 5 min and properly positioned in
a packed cell volume table for hematocrit scoring [34,35]. LDH
levels were determined with an analytical kit, as recommended by
the supplier (Laborclin, Brazil).
Lethal Infection with the JHA1 Isolate and
Histopathological Analyses
To evaluate the histopathological effects elicited by the JHA1
isolate, 9-week-old male Balb/c mice (n = 12) were injected i.c.
with 300 PFU of the viral stock. Mice were bled via the retro-
orbital plexus (n = 6) on days 2, 4, 6 and 7 p.i. for individual serum
sampling. The samples were used to test the reactivity of
antibodies to recombinant NS1 and EIII proteins (days 2, 4, 6
and 7 p.i.) and INF-c production (day 7 p.i.). For blood cell
analyses, the animals were bled on days 4, 7 and 8 p.i. (n = 6), and
the blood samples were transferred to microtubes containing
EDTA (0.375 M). On the day 8 p.i. (moribund state), the animals
were euthanized, and the brains, spleens, lungs, kidneys, liver,
colon and bone marrow were removed and individually macerated
in DMEM at 4uC (3 mL for each brain, liver, couple of lungs or
kidneys, and individual colon; 2 mL for each spleen; and 0.5 mL
for each bone marrow). The macerates were transferred to 15-mL
plastic tubes and centrifuged for 5 min at 405 g. The virus
concentrations in the supernatants were determined using a plaque
assay on LLC-MK2 cells. For histological studies, the mice were
euthanized (n = 3), and the brains were fixed with 10% formal-
dehyde and processed and stained with hematoxylin and eosin.
IgG and Cytokine ELISA
Mice sera were tested individually for the presence of NS1 and
EIII-specific antibodies by ELISA, as previously described [36].
Briefly, MaxiSorp plates (Nunc, Denmark) were coated with
0.2 mg per well of the recombinant NS1 or EIII proteins (based on
the genome sequence of the NGC virus strain) in 100 mL PBS and
blocked for 1 h at 37uC with 5% skim milk in 0.05% Tween-20/
PBS (PBST). The serum samples were serially diluted and added
to wells previously washed with PBST. After 1 h at room
temperature, the plates were washed with PBST and incubated
with goat anti-mouse IgG conjugated with horseradish peroxidase
(Southern Biotechnology, USA) for 1 h at room temperature. The
reactions were measured at A492nm with ortho-phenylenediamine
dihydrochloride (Sigma-Aldrich, USA) and H2O2 as a substrate
after the addition of a 2 N H2SO4 stop solution. The titers were
established as the reciprocal of serum dilutions that yielded an
absorbance two-fold higher than the SD values of the respective
mock-infected animals. The serum samples collected on day 7 p.i.
were tested individually using an INF-c, IL-1b or TNF-a ELISA,
according to the manufacturer’s instructions (BD Bioscience,
USA).
Blood Cell Analyses
Whole blood samples were used to evaluate six hematological
parameters: red blood cell (RBC) and white blood cell (WBC)
counts, hematocrit (HTC), platelet number (PTL) and lymphocyte
(LYM) and neutrophil (NEU) differentiation. RBC and WBC
counts were performed using a Neubauer chamber, HCT was
determined as described above, PLT numbers were determined
according to Fonio’s method, and NEU and LYM differentiation
was performed visually using a phase-contrast microscope [34,35]
(Eclipse E200 model, Nikon, Japan). At the day 7 p.i., mouse
plasma were used to perform the prothrombin time test according
to the kit manufacturer’s instructions (Bioclin, Brazil).
Determination of Cross-reacting Epitopes Shared by the
Envelope Proteins of the JHA1 and NGC Strains
The immunological relationship between the JHA1 and NGC
strains was demonstrated by the labeling of infected cells and virus-
neutralization assays performed with antibodies raised in mice
immunized with domain III of the recombinant envelope (EIII)
protein derived from the NGC strain. Anti-EIII antibodies were
obtained in Balb/c mice subjected to an immunization regimen of
three doses administered subcutaneously (s.c.) (days 0, 14 and 28)
and containing 10 mg of the recombinant EIII combined with
complete Freund’s adjuvant (50% v/v) (first dose) and incomplete
Freund’s adjuvant in the subsequent injections. The serum
samples were pooled, titered with the recombinant protein (final
reverse titer of 900,000) and used in JHA1-infected mammalian
cells. Sterile microscope cover slips were positioned in wells of
Nunc 6-well plates containing 105 cells/well (LLC-MK2) in
DMEM supplemented with 5% FBS. After incubation at 37uC
with 5% CO2 for 12 h, the cells were gently washed with sterile
PBS (pH 7), infected with JHA1 and suspended in DMEM at
a multiplicity of infection of 1 (MOI = 1) for 1 h at 37uC with 5%
CO2. The cells were incubated under the same conditions for 96 h
and then fixed with 4% paraformaldehyde for 20 min at 4uC,
permeabilized with saponin and treated with the anti-EIII serum
or serum from non-immune mice for 1 h at room temperature.
Subsequently, the cells were treated with goat anti-mouse IgG
DENV2 Clinical Isolate Inducing Hemorrhage in Mice
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conjugated to FITC (Invitrogen, USA) and DAPI (Thermo
Scientific, USA). The samples were analyzed using an immuno-
fluorescence microscope (Asiovert S100, Zeiss, Germany).
The serum samples were also tested for virus neutralization
activity using the JHA1 isolate in plaque assays with the LLC-
MK2 cell line, as previously described [37]. In brief, viral stock
aliquots were diluted to yield 40 plaques per well (in 6-well
plates). The serum pools from immunized or non-immune mice
were inactivated (56uC for 30 min), and serial two-fold dilutions
beginning at a 1:2 dilution were added to the virus suspension
in a final volume of 400 mL and incubated at 37uC for 1 h.
The incubation mixtures were seeded with 26105 LLC-MK2
cells and incubated for 1 h at 37uC with 5% CO2. After
incubation, the cells were covered with a mixture containing
E199 medium, 1% carboxymethyl cellulose and 2% FBS and
incubated at 37uC with 5% CO2 for 7 days for viral plaque
formation.
The examination of cross-reactive epitopes shared by the NGC
and JHA1 strains was also performed with the PREDBALB/C
program that predicted the specific class I and II MHC epitopes
for Balb/c mice [38]. The epitopes with high scores were
compared in both DENV2 strains. The experimentally de-
termined MHC-I-restricted CD8+ T cell-specific NS1 epitope
(AGPWHLGKL) was also compared in both virus strains [39,40].
Statistical Analyses
Statistical analyses were performed using a Student’s t-paired
test or ANOVA and a subsequent Bonferroni’s multiple compar-
ison test. Statistical significance was set as p,0.05.
Results
Genetic Study of the DENV JHA1 Strain
Sequencing of the genes encoding the E (domain III, stem-
anchor region and NS1 signal peptide) and NS1 proteins of the
JHA1 strain, ranging from nucleotides 1822 to 3477 of the virus
genome, and phylogenetic analyses with orthologous nucleotide
sequences of different DENV and yellow fever virus (YFV)
strains available at the Genbank demonstrated that the strain
was a type 2 dengue virus that lies within the American
genotype (Figure 1A). Comparison of the amino acid sequences
of the JHA1 strain with other DENV2 strains, including the
mouse-adapted neurovirulent NGC strain, revealed 23 poly-
morphic sites (Figure S1). Among these, three polymorphic sites
were located on sites previously shown to be involved in
neurovirulence in mice [20]. The replacements of an aspartic
acid (D) with an asparagine (N) and a phenylalanine (F) with
a leucin (L) at positions 390 and 402 of the envelope
glycoprotein (E protein), respectively, as well as the replacement
of an arginine (R) with a glutamine (Q) at position 105 of the
NS1 protein, were ascribed to neurovirulence in mice. These
replacements were present in the NGC strain but absent in the
other two DENV2 strains isolated from human subjects
(Figures 1B, 1C and Table S1). Additional unique polymorphic
sites in the E protein sequence of the JHA1 strain were
detected, including the replacement of a methyonine (M) with
an alanine (A) at position 301, the replacement of a threonine
(T) with a glycine (G) at position 303 (see Figure S1) and the
replacement of a serine (S) with an arginine (R) at position 363
(see Fig. 1B). Collectively, the sequence analyses indicated that
the JHA1 strain would naturally possess features of the NGC
strain, particularly regarding neurovirulence in mice.
The DENV2 JHA1 Strain is Lethal in Immunocompetent
Adult Mice
After isolation, the JHA1 strain was propagated in the C3/36
cell line and tested for lethality in adult Balb/c mice following i.c.
administration. Under these conditions, all animals inoculated
with 4,000 PFU of the JHA1 died 5 days later. Subsequent
experiments performed to determine the minimum lethal dose
showed that the JHA1 strain had an estimated LD50 of 50 PFU,
while the smallest tested dose (25 PFU) caused a final lethality of
20% under the test conditions (Fig. 2A). Mice infected with 100,
150, 200 or 300 PFU died between 8 and 15 days after challenge
and exhibited statistically significant body weight loss compared
with the mock-treated animals (Figure 2B). Mice infected with
lethal virus loads had morbidity signs (hind limb paralysis and
distorted spinal cords) within 24 h before dying; however,
morbidity signals were not detected among survivors (data not
shown). In addition, the hematocrit values of mice infected with
300 PFU showed a significant increase seven days after challenge
when compared with the control group and mice infected with
lower viral loads (Figure 2C). Moreover, the serum LDH levels
were increased in mice infected with 200 and 300 PFU in
comparison to mock-infected animals, suggestive of general tissue
damage (Figure 2D). Virus obtained from infected mice were
further submitted to sequencing of the genes encoding the EIII,
stem-anchor region and NS1 protein and no acquired mutations
could be detected with regard to the parental strain (data not
shown). Together, these results indicate that the JHA1 strain can
kill adult Balb/c mice infected via the i.c. route by causing general
tissue injury, including hematological disturbances indicative of
plasma leakage.
Hematological Alterations and Brain Damage in Mice
Infected with the JHA1 Strain
To investigate the hematological disturbances detected in mice
infected with the JHA1 isolate, the animals were inoculated i.c.
with 300 PFU (66LD50), and the number of red cells, white cells,
and platelets, as well as the hematocrit values, were monitored. As
shown in Table 1, no significant cellular parameter was altered on
day 4 p.i. However, a clear increase in the hematocrit values and
a sharp decrease in the number of white blood cells were observed
in JHA1-infected mice 7 days after the challenge. One day later,
there was a sharp decrease in the hematocrit values and red blood
cell count in virus-infected animals. At this time point, most of the
animals were in a moribund state and had begun to die (Table 1).
The numbers of lymphocytes and neutrophils were also reduced
on days 7 and 8 p.i., but no alteration in the platelet numbers
could be detected in mice infected with the JHA1 strain. In
contrast, a significant alteration in the coagulation pattern,
measured by the prothrombin-dependent coagulation time, was
detected in JHA1-infected mice. The prothrombin time was
increased by approximately ten-times in mice infected with the
JHA1 strain with regard to mock-treated mice, an indication that
the coagulation function was drastically impaired among infected
mice (Table 1). In addition to the hematological disturbances, the
JHA1 strain resulted in brain tissue damage. As shown in
Figure 3A, extensive gliosis scars were observed in brain tissue
samples collected from mice infected with the JHA1 strain.
Moreover, mononuclear cells were detected in the blood vessels
and the surrounding brain parenchyma but were not observed in
samples collected from the mock-treated animals (Figures 3D and
3F). No apparent spleen or liver damage could be detected in mice
infected i.c. with the JHA1 strain (data not shown). These results
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indicate that the JHA1 strain kills mice mainly via encephalitis
with extensive tissue damage.
Replication and Induction of Inflammatory and Adaptive
Immune Responses in JHA1-infected Mice
To determine whether the JHA1 strain remained viable in the
tissues of infected mice, organ (brain, spleen and liver) and blood
samples were collected 7 days after the challenge with 300 PFU.
Viable virus particles were detected in the brains of infected mice
(mean number of 70,832633,228 PFU/brain). The virus was also
detected in the spleens of infected mice, albeit at lower levels
(3336376 PFU/spleen). No viable virus particles could be
recovered from the blood, liver, lungs, kidneys, colon and bone
marrow samples. The production of IFN-c in the serum of virus-
infected animals was also determined to be an indication of an
acute inflammatory reaction. As indicated in Figure 4B, the IFN-c
serum concentration was significantly enhanced in mice infected
Figure 1. Genetic study of the JHA1 DENV2 strain recovered from a symptomatic subject. (A) Phylogenetic tree showing that the JHA1
strain (indicated by the rectangle) is grouped within the type 2 dengue viruses based on nucleotide sequences encompassing the envelope protein
(domain III of the E protein) and the NS1 protein. The JHA1 strain was clustered in the American genotype (India/1957, American Samoa/1972 and
Indonesia/1977) strains. Numbers at the nodes are bootstrap values (1000 replicates). DENV sequences were retrieved from GenBank as identified on
the right side of the figure. In most cases, the sequences were also identified by the virus isolation area and the year of isolation. (B) Genetic analyses
of polymorphic sites within the main envelope (E) protein sequence of the JHA1 strain were performed with the NGC strain, which served as the
model for neurovirulence in mice, and the India/1957 and Indonesia/1977 strains, which are unable to infect mice. One amino acid substitution in the
JHA1 strain was identical (position 390) and another was similar (position 402) to those observed at the same positions of the NGC strain but not in
the other DENV2 strains. Other mutations at positions 301, 303 and 363 of the JHA1 E protein are unique to the JHA1 strain. (C) Genetic analysis of
polymorphic sites of the deduced NS1 amino acid sequence. The amino acid replacement at position 105 was found in the NGC strain but not in the
other DENV2 strains.
doi:10.1371/journal.pone.0044984.g001
Figure 2. The JHA1 isolate is lethal to immunocompetent mice and causes tissue damage. (A) Survival curves of male Balb/c mice infected
i.c. with different viral loads (25 to 300 PFU) in a final volume of 40 mL. Mice were monitored for 21 days after the challenge. (B) Body weight loss in
mice infected with the JHA1 strain. The body weights of infected and mock-infected animals were monitored daily, and the differences between the
initial and final measurements were calculated and are presented as percentages. (C) Hematocrit determination in mice infected with the JHA1 strain.
The animals were bled on the seventh day after the challenge. (D) Serum LDH levels in JHA1-infected mice. The serum samples were collected 7 days
after the challenge. Statistically significant differences were determined with the ANOVA test and a subsequent Bonferroni’s multiple comparison
test. Statistically significant differences are indicated with asterisks: *, p,0.05; **, p,0.01; and ***, p,0.001. Data are representative of three
independent experiments.
doi:10.1371/journal.pone.0044984.g002
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with the JHA1 strain compared with the mock-treated animals.
But IL-1b and TNF-a were not detected in mice sera of both
groups (data not shown). In addition, a dramatic increase in the
anti-NS1 serum IgG titers and, to a lesser degree, the anti-EIII
IgG levels was detected in the serum of JHA1-infected mice
(Figure 4C). Neither NS1 nor EIII-specific antibody responses
were detected in mock-infected mice, as evaluated both by ELISA
and Western blot (Figure 4C and data not shown). Collectively,
these results indicate that the JHA1 strain replicates and induces
acute inflammatory reactions and early adaptive immune
responses in adult mice infected via the i.c. route.
Figure 3. Pathological brain tissue alterations in mice infected with the JHA1 strain. (A) Mock-treated mice with preserved brain
parenchyma with typical cellular components. (B) Brain tissue of JHA1-infected mice showing a gliosis scar, in which dead neurons were replaced by
astrocytes. The gliosis scar is indicated by the arrows. (C) Brain blood vessel (transverse view) in mock-treated mice. (D) Brain blood vessel in JHA1-
infected mice filled with mononuclear cells (arrow). Some of the cells are observed outside the endothelial epithelium (asterisk) and are present in the
brain parenchyma (arrowheads). (E) Brain blood vessel (longitudinal view) in mock-treated mice. (F) Brain blood vessel of JHA1-infected mice with
infiltration of mononuclear cells (arrowheads). Infected and mock-infected mice were euthanized on day 8 p.i. Brain tissue samples were fixed with
1% formaldehyde, processed and stained with hematoxylin and eosin. Magnification: 400x. Images are representative of three independent
experiments.
doi:10.1371/journal.pone.0044984.g003
DENV2 Clinical Isolate Inducing Hemorrhage in Mice
PLOS ONE | www.plosone.org 7 September 2012 | Volume 7 | Issue 9 | e44984
The JHA1 Strain Shares Immunological Determinants
with the NGC Strain
In contrast to the DENV2 NGC strain, a viral strain adapted for
neurovirulence in mice [41], our results demonstrated that the
JHA1 strain was capable of replicating and killing adult Balb/c
mice infected via the i.c. route without the need of adaptation steps
for the new host. As the NGC strain represents a reference strain
both in studies focusing on DENV pathogenesis and the evaluation
of anti-dengue vaccine efficacy, we determined the extent of
common immunological determinants between the NGC and
JHA1 DENV2 strains. Computational analysis performed with the
PREDBALB/C program indicated that the class I and II MHC-
restricted epitopes of the E glycoprotein (domain III and stem-
anchor region) and the NS1 proteins were identical in both virus
strains (Table S2). In addition, sera collected from mice
immunized with a recombinant EIII protein derived from the
NGC were capable to recognize the protein found in JHA1
(Figure 5). As indicated in Figures 5A and 5B, sera of sham-treated
mice did not recognize the viral particles inside infected cells, while
anti-EIII antibodies, raised in mice immunized with a recombinant
Table 1. Hematological alterations detected in mice infected with the JHA1 straina.
Hematological Day 4 p.i. Day 7 p.i. Day 8 p.i.c
Parametersb Mock-infected Infected Mock-infected Infected Mock-infected Infected
HCTd 40.361.6 39.361.2 40.861.9 44.5* 62.0 40.661.7 30.0*** 62.0
RBC 7.663.0 7.961.2 8.760.7 11.163.3 8.060.6 5.8*** 61
WBC 9.061.9 5.863.2 11.060.5 2.4*** 60.6 8.461.1 2.5*** 60.6
LYM 5.862.4 4.662.9 8.360.8 1.7*** 60.4 7.960.8 1.5*** 60.5
NEU 2.060.5 1.060.8 1.760.2 0.6*** 60.2 1.260.1 0.5*** 60.2
PLT 1.260.1 1.260.1 1.360.2 1.360.2 1.260.1 1.260.2
PTe 19.565.4 217.26115**
aMale Balb/c mice (n = 12) were inoculated i.c. with 300 PFU of the JHA1 strain or mock-treated. Mice were bled via the retro-orbital plexus on days 4, 7 and 8 p.i. for
hematological analyses.
bBlood samples were processed to determine the concentration of red blood cells (RBCs), white blood cells (WBCs), lymphocytes (LYMs), neutrophils (NEUs), and
platelets (PLTs). WBC, NEU, LYM and PLT counts are expressed as 103 cells/mL. RBC counts are expressed as 106 cells/ml.
cOn day 8 p.i., the animals had morbidity signals, such as hind limb paralysis and spine cord curvature, which was indicative of a moribund state.
dHematocrit (HCT) values are given as percentages (%) of packed cell volume. Data are expressed as the mean 6 SD of individual measurements. Comparisons between
mock-treated and virus-infected mice were performed by t-paired tests on days 4, 7 and 8 p.i., with statistical significance set as p,0.05. (*) p,0.05; (**) p,0.01; (***)
p,0.001. The results are based on one representative experiment of three independently performed experiments yielding similar results.
eThe prothrombin times (PT) were individually measured on day 7 p.i. both in mock-treated and virus infected mice, in order to access coagulation mechanism integrity.
Values are given in seconds. A t-paired test was performed, with statistical significance set as p,0.05. (*) p,0.05; (**) p,0.01; (***) p,0.001 regarding mock-treated and
infected groups.
doi:10.1371/journal.pone.0044984.t001
Figure 4. Determination of viable virus particles and induction of inflammatory and adaptive immune responses in mice infected
with the JHA1 strain. (A) Replication of the JHA1 strain in brain and spleen tissues. Mice infected i.c. with 300 PFU were euthanized on day 7 p.i.,
and both the brains and spleens were removed and processed as described in the Methods section. (B) Quantification of INF-c levels in the serum
samples of mice infected with the JHA1 strain. The serum samples were collected seven days after the challenge. (C) Virus-specific serum IgG
responses induced in mice infected with the JHA1 strain. The serum samples collected on days 2, 4, 6 and 7 p.i. were tested individually for the
presence of NS1- or EIII-specific antibodies by ELISA. Background values detected in serum samples collected from mock-treated animals were
reduced from those measured among virus-infected mice.
doi:10.1371/journal.pone.0044984.g004
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protein derived from the NGC strain, reacted with the JHA1
particles (Figures 5C and 5D). Moreover, the same anti-EIII serum
was shown to neutralize the JHA1 strain, as demonstrated in virus-
neutralization assays (Figure 5E). Considering similar cross-
reactivity of the NS1-specific antibodies (Figure 4C), these
evidences indicate that the JHA1 and NGC strains share
important immunological determinants both in the main envelope
glycoprotein and the NS1 protein.
Discussion
The incidence of DF and DHF/DSS cases has dramatically
increased during the last decade in different parts of the tropical
world and particularly among Latin America countries, in which
the disease has assumed a seasonal epidemic character with
remarkable numbers of infected subjects and fatalities [42,43].
This scenario is worsened by the fact that the viral pathogenicity,
particularly regarding aspects dictating the infection course and
the onset of more serious symptoms, has not been elucidated. This
knowledge gap is attributed at least in part to the lack of adequate
experimental models that reproduce the pathological and immu-
nological events either leading to the disease or controlling it. In
the present study, we described the characterization of a DENV2
strain, named JHA1, which is naturally lethal to mice. After
isolation from a symptomatic patient, a virus seed stock was
obtained after a minimal number of replication rounds and
Figure 5. The JHA1 and NGC strains share immunological determinants within the major envelope protein. LLC-MK2 cells were
infected with the JHA1 strain and probed with a serum pool raised in mice immunized with EIII derived from the NGC strain or in non-immune
animals. (A) Phase-contrast microscopy of the infected cells probed with serum from sham-treated mice. (B) Immunofluorescence microscopy of the
infected cells probed with serum from sham-treated mice. The photograph was merged with the same field observed using phase-contrast
microscopy. (C) Phase-contrast microscopy of infected cells probed with the anti-EIII serum pool. (D) Immunofluorescence microscopy of infected
cells probed with the serum pool of mice immunized with the EIII protein derived from the NGC strain JHA1. The picture was merged with the same
field observed in phase contrast. (E) Virus neutralization assay performed with the serum from JHA1-infected mice immunized with the EIII protein
derived from the NGC strain. Aliquots containing 40 PFU were incubated with different dilutions of the anti-EIII serum pool (ranging from 1:2 to
1:8,192) for 30 min and subsequently transferred to wells with LLC-MK2 cells. One week later, the number of virus plaques was counted.
Magnification: 400x. Images are representative of three independent experiments.
doi:10.1371/journal.pone.0044984.g005
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demonstrated to replicate, induce symptoms and kill Balb/c mice
infected via the i.c. administration route. The exacerbate murine
virulence of the JHA1 strain probably lies in the natural genetic
polymorphism of the virus, in which at least three amino acid
replacements were previously ascribed to DENV2 neurovirulence
in mice. JHA1-infected mice showed altered hematological
parameters similar to those observed in severe dengue cases, such
as plasma leakage and hemorrhage. The virus showed rather low
infective doses (LD50 of 50 PFU) after administration via the i.c.
route and, in addition, induced encephalitis, acute inflammatory
responses and early antibody responses to the NS1 and, to a lesser
extent, the envelope glycoprotein, in agreement with the
pathological signs detected among infected subjects. Together,
the present findings indicate that the JHA1 strain represents a new
and useful tool for the study of DENV pathogenicity and yields
promising perspectives regarding the development of a more
rational and effective screening program for drugs and vaccine
candidates.
A phylogenetic analysis grouped the JHA1 strain as a type 2
DENV (DENV2) strain clustered within strains of the American
genotype. Interestingly, representative viruses of this group were
isolated in India, American Samoa and Indonesia, which is
explained by the transmission of DENV2 strains between Asia and
the Americas sometime around 1948 [44,45]. The DENV2 JHA1
strain was also shown to carry important genetic markers
associated with neurovirulence in mice when compared with
strains of the same genotype. Two amino acid replacements,
D390N and F402L, in the E protein were previously found to be
related to neurovirulence in mice [20]. In addition, the re-
placement at position R105Q of the NS1 protein was also found to
be related to neurotropism in mice and is identical or equivalent to
those replacements observed in the DENV2 NGC strain [20].
Other amino acid replacements, specifically located at the EIII
(positions 301, 303 and 363), were found only in the JHA1 strain.
Although not yet ascribed to murine neurovirulence, mutations in
this domain that are directly involved in binding host cell receptors
may affect host-virus interactions [46–48]. The higher virulence of
the JHA1 strain compared with the NGC strain, as inferred both
by the lower LD50 and the lack of morbidity signs among animals
who survived a sublethal dose [22,35,49,50], may also be
attributed to the unique amino acid replacement detected in the
E/NS1 protein sequence as well as in other protein sequences of
the virus.
The JHA1 strain shares immunological determinants with the
reference DENV2 NGC strain, as demonstrated by the specific
reactivity of anti-EIII and anti-NS1 antibodies. To date, the NGC
strain has been frequently used in studies employing immuno-
competent mice and as the genetic background for the construc-
tion of chimeric-, DNA- and protein-based DENV2 vaccine
candidates [4,16,22,35,50,51]. The present data demonstrated
that the JHA1 strain may represent a complementary tool for the
evaluation of NGC-based vaccine candidates. In addition, our
results indicate that the JHA1 strain may also be used in
experimental models without the need to determine how to
handle a virus strain in which different mutations have been
selected during adaptation to the new host, which is therefore
different from the original virus strains.
Pathological damage caused by the JHA1 strain was mainly
restricted to the brain and local endothelial cells. In contrast to
DHS/DHF cases [43,52], no significant pathological damage was
detected in the liver or spleen of the infected animals. This
indicates that the cellular targets of the JHA1 strain are mainly
restricted to the cerebral tissue, leading to death by encephalitis.
Such pathological features may restrict the dissemination of the
virus to other tissues, as supported by the unsuccessful attempts to
infect mice with the JHA1 strain using other administration routes
(unpublished observations). Nevertheless, the detection of viable
virus particles in the spleen and the induction of rather early virus-
specific antibody responses indicate that at least some virus
particles leak from the cerebral tissue and may reach distant
organs. The presence of viable virus particles in the spleen may
also be a consequence of the high concentration of mononuclear
cells in this organ, known to be permissive to DENV replication
[1,2,14]. Some of the features detected in mice lethally infected
with the JHA1 strain have also been observed in infected subjects
with unusual DENV infection manifestations, who suffer from
pain ascribed to transient encephalitis and weight loss [53–56].
Other DENV experimental models based on immunocompro-
mised mice could also reproduce some of these symptoms
(encephalitis and weight loss) but in a different time period [25].
The fact that the JHA1 virus could replicate and kill immuno-
competent mice without accumulation of selective mutations
allowing adaptation to the new host emphasizes the fact that the
natural genetic variability of the virus may hinder relevant
information regarding host specificity and tissue tropism among
immunocompetent hosts.
Specific hematological alterations observed in JHA1-infected
mice were similar to those recorded in severe DENV infection
cases, such as the transient increase in hematocrit values followed
by a sharp decrease indicative of hemorrhage [25,54,57,58]. In
addition, the observed reduction in the number of lymphocytes
and neutrophils has also been recorded in DHF and DSS cases in
which the depletion of progenitor cells occurs due to medullar
virus replication [34,59–62]. In contrast, no alteration was
observed in the platelet number during the infection course,
which is a hallmark DHF characteristic. A similar feature was also
reported for a DENV3 strain capable of infecting immunocom-
petent mice [26]. However, the coagulation function in mice
infected with the JHA1 strain was drastically altered, as measured
by the prothrombin time test. This result has a close relationship
with the hemorrhage process observed in the JHA1-infected
animals and may also be related to the high levels of anti-NS1
antibodies detected in these mice, once that such antibodies were
previously shown to interfere with coagulation mechanisms
[4,6,7]. Nevertheless, the conclusion that the JHA1 strain
reproduces, under experimental conditions, most of the hemato-
logical disturbances observed in severe forms of DENV infection
cases must be considered in future studies that are designed to
provide a better understanding of viral pathogenicity.
The JHA1 strain was also shown to induce acute inflammatory
reactions and early adaptive immune responses in infected mice.
Infected animals had increased serum levels of INF-c, an
important antiviral cytokine that is lacking in AG129 mice
(lacking interferon-a/b and -c receptors), which are frequently
used as a DENV infection model [24,25] Thus, the lack of
detectable virus particles in blood samples and histological injuries
in organs other than the brain of mice infected with the JHA1
strain may be attributed to the early virus replication control
triggered by the rapid increase in INF-c in immunocompetent
Balb/c mice. Similar to the response detected in humans [63],
early antibody responses detected in mice infected with the JHA1
strain were mainly associated with the NS1 protein. These results
are indicative of the higher immunogenicity of the NS1 protein
compared with the E protein and reflect the early synthesis and
secretion of the NS1 protein during the infection course [43,63].
Together, these findings indicate that in mice, the JHA1 strain can
reproduce some of the inflammatory reactions and early antibody
responses that are detected in DENV-infected subjects without the
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need to use genetically modified mice. Such features open the
possibility of using the JHA1 strain to evaluate immunization
regimens that induce protective innate and adaptive immune
responses leading to protection from lethal virus challenges.
It is important to highlight that the results presented in this
study were obtained by using an inbred immunocompetent mouse
lineage, which differ from conditions naturally found among
human populations. Probably some of the reported symptoms and
features observed in JHA1-infected mouse may differ from those
observed in outbred animals. Nonetheless, all experimental
murine models aiming to the study of dengue pathogenesis are
based on isogenic lineages [6,26,64]. In addition, the infection
route presented in this study is clearly far from that observed in the
infection natural course, with disease symptoms based mainly on
encephalitic manifestations, which are accepted as unusual
manifestations in infected humans [53–56], but in contrast, were
also reported in other mouse models with DENV inoculation
through the intracranial route [65–67]. Thus, the infection model
presented here is not able to reproduce the complete set of
symptoms seen in DF or its more severe forms, DHF and DSS.
Nonetheless, we report here, for the first time, the contribution of
reproducing most of the hematological disturbances seen in
infected humans by using non-modified virus and mice. Despite
the important differences regarding the natural infection, the
present model represents a step forward in the study of different
aspects of DENV pathogenesis and may help of the screening of
different anti-viral approaches.
In conclusion, the present study provides important contribu-
tions to the study of DENV2 pathogenicity that may aid the
development of antivirus prophylactic and therapeutic ap-
proaches. As previously observed [26], our results demonstrate
that the endogenous DENV2 genetic plasticity represents an
important source of information that may contribute to a better
understanding of viral pathogenicity, including the ability of
viruses to replicate in a murine host and the severity of the induced
symptoms. These results also indicate that a similar approach may
be applied to other DENV types that could lead to the
identification of virus strains with more adequate features for the
development of alternative infection models.
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Figure S1 Multiple sequence alignment of the amino
acid sequences corresponding to the EIII/NS1 region of
the JHA1, India/1957, Indonesia 1977 and NGC strains.
Polymorphic sites are indicated and placed into three different
regions of the analyzed sequences: domain III (red), stem-anchor
and NS1 signal peptide (blue) of the E protein (inside the black
rectangle) and the entire NS1 protein (outside of the black
rectangle).
(TIF)
Table S1 Comparison of amino acid sequences of the
envelope glycoprotein and nonstructural NS1 protein
regions possibly involved with neurovirulence in mice of
the NGC and JHA1 DEN2 strains.
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Table S2 Predicted T-cell epitopes shared by the JHA1
and NGC DENV2 strains found at the sequences
encoding the EIII/NS1 proteins. a Inferred amino acid
sequences of NGC and JHA1 strains were submitted to the
computational system PREDBALB/C to predict specific epitopes for
class I (H2-Kd, H2-Ld and H2-Dd) and class II (H2-IEd and H2-
IAd) MHC molecules of Balb/c mice (Zhang et al., 2005). The
predicted epitopes with higher scores were compared between the
two strains to infer the conservation of these immunological
determinants. This comparison was also applied to the experi-
mentally determined CD8+ T cell-restricted epitope of the
DENV2 NS1 protein, AGPWHLGKL (Gao et al., 2008).
b Predicted epitopes with higher scores within the EIII/NS1
region of the JHA1 isolate and the CD8+ T cell-restricted epitope
of the DENV2 NS1 protein, all of which were fully conserved
between the JHA1 and NGC strains. c Location of the conserved
epitope within the EIII/NS1 region of the strains subjected to the
analysis. d Epitope located in the NS1 protein previously
demonstrated to be specific for CD8+ T lymphocytes and widely
conserved among several DENV2 strains.
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